If SH3BP5 in DLBCL cells acts similarly as that in normal B cells, these findings suggest that SH3BP5 overexpression in DLBCL patients might be associated with a favorable prognosis. This evidence concerns the gene SH3BP5 and diffuse large B-cell lymphoma.